<?xml version="1.0" encoding="UTF-8"?>
<p id="p0005">Diabetes mellitus (DM) is a major chronic disease with persistent hyperglycaemia which is affecting global population at an alarming rate. In 2019, the global DM prevalence is estimated to be 9.3% (463 million people) and the total count is predicted to rise by 2045 (
 <xref rid="b0210" ref-type="bibr">Saeedi et al., 2019</xref>). Diabetes mellitus can deteriorate various organ systems due to the metabolic aberrations and immune dysfunction which can lead to various complications such as retinopathy, nephropathy, neuropathy, and increased risk of cardiovascular diseases (
 <xref rid="b0075" ref-type="bibr">Goyal and Jialal, 2020</xref>). The prevalence of co-morbidities like hypertension and obesity are seen commonly among people with DM (
 <xref rid="b0040" ref-type="bibr">Chaudhary et al., 2019</xref>). In DM, immune dysfunction occurring in a hyperglycaemic environment leads to the greater frequency of bacterial infections associated with acute and emphysematous pyelonephritis, abscess, gangrene, foot infections, and external otitis as well as fungal infections associated with cystitis and candidiasis (
 <xref rid="b0035" ref-type="bibr">Casqueiro et al., 2012</xref>). Without integrated pharmaceutical and medical nutrition therapy, DM could be disabling, life-threatening, and expensive.
</p>
